Figure 1: Chest X-ray revealed a mass-like opacity on the right ninth rib.
Figure 3: Technetium-99m methylene diphosphonate scintigraphy showing a suspicious malignant lesion.
The condition is categorized as primary xanthoma when other diseases have been ruled out.[2] In xanthoma with hyperlipoproteinemia, bone marrow may be progressively infiltrated and replaced by lipid deposits, resulting in trabecular and cortical bone resorption.[4] In xanthoma without lipid disorders, according to one hypothesis, the possible appearance of the lesion is the result of a reactive response to intramedullary hemorrhage following trauma.[2,6] Curiously, our patient had no history of trauma, and his lipid profile was within normal limits.
Primary xanthoma of the bone is seen twice as often in men (average age 20-50 years).[1,2,7] Our patient was a 38-year-old men who was good in health. The initial symptom of primary xanthoma of the bone is believed to be pain, but 30% of the patients with this condition are asymptomatic.[2,7] In our case, the patient was admitted with chest pain.
Radiologically, xanthoma of the bone almost always appears in a solitary form and most frequently is located in flat bones.[1,7] In patients with lipid disorders, the lesions are mostly multifocal and are especially found in the lower limbs.[2] This tumor is benign in appearance and has a purely lytic matrix and good margination.[2] In our case, despite the benign appearance radiologically, the bone scintigraphy findings with 20 mCi of Tc-99m MDP suggested a malignant lesion. Therefore, costal xanthoma should be considered in the differential diagnosis of diseases which produce xanthomatous changes.[1]
A diagnosis of xanthoma is based on histological findings. Microscopically, foam cells, macrophages, cholesterol, fibrosis, and hemosiderin often exist.[2] Xanthomatous lesions of the bone may also be observed as secondarily with various bone lesions, including malignant tumors. Such lesions also appear as xanthomatous nodules in primary and secondary hypercholesterolemic states, xanthomatous areas in meningiomas, histocytosis X, benign and malignant fibrous xanthomas (histiocytomas), Erdheim- Chester disease (multicyctic granulomatosis), Rosai-Dorfman disease (bone involvement in sinus histiocytosis with massive lymphadenopathy), and xanthogranulomatous osteomyelitis. Subsequently, bone damages with a predominantly xanthomatous component and lesions which have a histological description, such as defective metaphyseal fibrous defect, benign fibrous histiocytoma, aneurysmal bone cysts, simple cysts, fibrous dysplasia, osteomyelitis, histiocytosis, and metastatic clear cell carcinoma should be considered in differential diagnosis.[1,7] When diagnosis is difficult, an immunohistochemical analysis of the tissue may be helpful, especially when a specimen can be obtained via a needle biopsy.[2] In our case, we did not need a preoperative biopsy, and a complete resection of the lesion was planned because of its well-defined margination. The aim of this procedure was to make a definitive diagnosis and then resolve the issue.
In xanthoma with lipid disorders, medical treatment can be sufficient, whereas in xanthoma without hyperlipoproteinemia, a complete or partial removal of the lesion should be the treatment of choice.[2] Xanthomas may recur if any underlying disorders are left untreated. Thus, medical treatment should be continued after the excision of the xanthoma in cases of hyperlipidemia.[5] In cases of xanthoma without hyperlipidemia, two studies reported that there were no recurrences after the surgical excision.[2,5] We also observed no recurrence after the complete surgical excision in our case.
In conclusion, costal xanthoma is an exceptional diagnosis in normolipidemic patients. We believe that xanthoma should be considered in the differential diagnosis of costal lesions that are seemingly benign when viewed on X-rays but are revealed to be malignant on scintigraphy. In these cases, complete surgical excision should be performed.
Declaration of conflicting interests
The authors declared no conflicts of interest with
respect to the authorship and/or publication of this
article.
Funding
The authors received no financial support for the
research and/or authorship of this article.
1) Kuroiwa T, Ohta T, Tsutsumi A. Xanthoma of the temporal
bone: case report. Neurosurgery 2000;46:996-8.
2) Ayadi-Kaddour A, Mlika M, Marghli A, Kilani T, El
Mezni F. Xanthoma of the rib without hyperlipoproteinemia.
Respiratory Medicine CME 2008;1:40-2.
3) Lee JY, Pozderac RV, Domanowski A, Torres A. Benign
histiocytoma (xanthoma) of the rib. Clin Nucl Med
1986;11:769-70.
4) Inserra S, Einhorn TA, Vigorita VJ, Smith AG. Intraosseous
xanthoma associated with hyperlipoproteinemia. A case
report. Clin Orthop Relat Res 1984;187:218-22.
5) Elwood ET, Shahwan TG, Dajani N, Murray JD. Isolated
xanthoma of the frontal bone. J Craniofac Surg 2005;16:391-4.
6) Parker F. Normocholesterolemic xanthomatosis. Arch
Dermatol 1986;122:1253-7.